← Back to Search

Proof-of-concept trial for Brain Metastases (AIM 2 Trial)

N/A

Waitlist Available

Led By Ashlee R Loughan, PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to evaluate and adapt CALM therapy for caregivers of patients with neurological cancers. The goal is to provide better emotional support through counseling sessions that help manage stress and improve well-being. CALM therapy is a brief individual psychotherapy designed to help patients with advanced cancer cope with emotional distress and promote psychological well-being.

Eligible Conditions

Cancer Brain Metastases
Caregiver
Neuro-Oncology

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Evaluate suitability of the CALM intervention to the needs of caregivers in neuro-oncology by measuring caregiver satisfaction.

Evaluate suitability of the CALM intervention to the needs of caregivers in neuro-oncology by measuring caregivers' recommendations to the content and format of the intervention during an exit-interview.